Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 50 entries
Sorted by: Best Match Show Resources per page
Synergizing expectation and execution for stroke communities of practice innovations.

Implementation science : IS

Poissant L, Ahmed S, Riopelle RJ, Rochette A, Lefebvre H, Radcliffe-Branch D.
PMID: 20529305
Implement Sci. 2010 Jun 08;5:44. doi: 10.1186/1748-5908-5-44.

BACKGROUND: Regional networks have been recognized as an interesting model to support interdisciplinary and inter-organizational interactions that lead to meaningful care improvements. Existing communities of practice within the a regional network, the Montreal Stroke Network (MSN) offers a compelling...

Cite
Poissant L, Ahmed S, Riopelle RJ, et al. Synergizing expectation and execution for stroke communities of practice innovations. Implement Sci. 2010;5:44doi: 10.1186/1748-5908-5-44.
Poissant, L., Ahmed, S., Riopelle, R. J., Rochette, A., Lefebvre, H., & Radcliffe-Branch, D. (2010). Synergizing expectation and execution for stroke communities of practice innovations. Implementation science : IS, 544. https://doi.org/10.1186/1748-5908-5-44
Poissant, Lise, et al. "Synergizing expectation and execution for stroke communities of practice innovations." Implementation science : IS vol. 5 (2010): 44. doi: https://doi.org/10.1186/1748-5908-5-44
Poissant L, Ahmed S, Riopelle RJ, Rochette A, Lefebvre H, Radcliffe-Branch D. Synergizing expectation and execution for stroke communities of practice innovations. Implement Sci. 2010 Jun 08;5:44. doi: 10.1186/1748-5908-5-44. PMID: 20529305; PMCID: PMC2890694.
Copy Download .nbib Format: NLM
Characterization of midostaurin as a dual inhibitor of FLT3 and SYK and potentiation of FLT3 inhibition against FLT3-ITD-driven leukemia harboring activated SYK kinase.

Oncotarget

Weisberg EL, Puissant A, Stone R, Sattler M, Buhrlage SJ, Yang J, Manley PW, Meng C, Buonopane M, Daley JF, Lazo S, Wright R, Weinstock DM, Christie AL, Stegmaier K, Griffin JD.
PMID: 28881711
Oncotarget. 2017 Jul 06;8(32):52026-52044. doi: 10.18632/oncotarget.19036. eCollection 2017 Aug 08.

Oncogenic FLT3 kinase is a clinically validated target in acute myeloid leukemia (AML), and both multi-targeted and selective FLT3 inhibitors have been developed. Spleen tyrosine kinase (SYK) has been shown to be activated and increased in FLT3-ITD-positive AML patients,...

Cite
Weisberg EL, Puissant A, Stone R, et al. Characterization of midostaurin as a dual inhibitor of FLT3 and SYK and potentiation of FLT3 inhibition against FLT3-ITD-driven leukemia harboring activated SYK kinase. Oncotarget. 2017;8(32):52026-52044doi: 10.18632/oncotarget.19036.
Weisberg, E. L., Puissant, A., Stone, R., Sattler, M., Buhrlage, S. J., Yang, J., Manley, P. W., Meng, C., Buonopane, M., Daley, J. F., Lazo, S., Wright, R., Weinstock, D. M., Christie, A. L., Stegmaier, K., & Griffin, J. D. (2017). Characterization of midostaurin as a dual inhibitor of FLT3 and SYK and potentiation of FLT3 inhibition against FLT3-ITD-driven leukemia harboring activated SYK kinase. Oncotarget, 8(32), 52026-52044. https://doi.org/10.18632/oncotarget.19036
Weisberg, Ellen L, et al. "Characterization of midostaurin as a dual inhibitor of FLT3 and SYK and potentiation of FLT3 inhibition against FLT3-ITD-driven leukemia harboring activated SYK kinase." Oncotarget vol. 8,32 (2017): 52026-52044. doi: https://doi.org/10.18632/oncotarget.19036
Weisberg EL, Puissant A, Stone R, Sattler M, Buhrlage SJ, Yang J, Manley PW, Meng C, Buonopane M, Daley JF, Lazo S, Wright R, Weinstock DM, Christie AL, Stegmaier K, Griffin JD. Characterization of midostaurin as a dual inhibitor of FLT3 and SYK and potentiation of FLT3 inhibition against FLT3-ITD-driven leukemia harboring activated SYK kinase. Oncotarget. 2017 Jul 06;8(32):52026-52044. doi: 10.18632/oncotarget.19036. eCollection 2017 Aug 08. PMID: 28881711; PMCID: PMC5581010.
Copy Download .nbib Format: NLM
Forethought in Youth with Attention Deficit/Hyperactivity Disorder: An fMRI Study of Sex-Specific Differences.

Psychiatry journal

Poissant H, Rapin L, Chenail S, Mendrek A.
PMID: 27529063
Psychiatry J. 2016;2016:6810215. doi: 10.1155/2016/6810215. Epub 2016 Jul 27.

Objective. The majority of studies investigating neurocognitive processing in attention deficit/hyperactivity disorder (ADHD) have been conducted on male participants. Few studies evaluated females or examined sex differences. Among various cognitive anomalies in ADHD, deficit in forethought seems particularly important...

Cite
Poissant H, Rapin L, Chenail S, et al. Forethought in Youth with Attention Deficit/Hyperactivity Disorder: An fMRI Study of Sex-Specific Differences. Psychiatry J. 2016;2016:6810215doi: 10.1155/2016/6810215.
Poissant, H., Rapin, L., Chenail, S., & Mendrek, A. (2016). Forethought in Youth with Attention Deficit/Hyperactivity Disorder: An fMRI Study of Sex-Specific Differences. Psychiatry journal, 20166810215. https://doi.org/10.1155/2016/6810215
Poissant, H, et al. "Forethought in Youth with Attention Deficit/Hyperactivity Disorder: An fMRI Study of Sex-Specific Differences." Psychiatry journal vol. 2016 (2016): 6810215. doi: https://doi.org/10.1155/2016/6810215
Poissant H, Rapin L, Chenail S, Mendrek A. Forethought in Youth with Attention Deficit/Hyperactivity Disorder: An fMRI Study of Sex-Specific Differences. Psychiatry J. 2016;2016:6810215. doi: 10.1155/2016/6810215. Epub 2016 Jul 27. PMID: 27529063; PMCID: PMC4978833.
Copy Download .nbib Format: NLM
[Collision sellar lesions: pituitary adenoma and Rathke cleft cyst].

Medicina

Padilla Lichtenberger F, Glerean M, Paissan A, Ajler P.
PMID: 34875610
Medicina (B Aires). 2021;81(6):1069-1072.

Rathke's cleft cyst (RCC) are a slow-growing, benign, cystic lesions that arises from the remnants of the primitive ectoderm and Rathke's pouch. They present a common origin with pituitary adenomas (PA), however, the concomitant presentation of a PA and...

Cite
Padilla Lichtenberger F, Glerean M, Paissan A, et al. Lesiones sincrónicas selares: adenoma hipofisario y quiste de la bolsa de Rathke. [Collision sellar lesions: pituitary adenoma and Rathke cleft cyst]. Medicina (B Aires). 2021;81(6):1069-1072
Padilla Lichtenberger, F., Glerean, M., Paissan, A., & Ajler, P. (2021). Lesiones sincrónicas selares: adenoma hipofisario y quiste de la bolsa de Rathke. [Collision sellar lesions: pituitary adenoma and Rathke cleft cyst]. Medicina, 81(6), 1069-1072.
Padilla Lichtenberger, Fernando, et al. "Lesiones sincrónicas selares: adenoma hipofisario y quiste de la bolsa de Rathke." [Collision sellar lesions: pituitary adenoma and Rathke cleft cyst]. Medicina vol. 81,6 (2021): 1069-1072.
Padilla Lichtenberger F, Glerean M, Paissan A, Ajler P. Lesiones sincrónicas selares: adenoma hipofisario y quiste de la bolsa de Rathke. [Collision sellar lesions: pituitary adenoma and Rathke cleft cyst]. Medicina (B Aires). 2021;81(6):1069-1072. Spanish. PMID: 34875610.
Copy Download .nbib Format: NLM
Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium.

Cancer discovery

Pikman Y, Tasian SK, Sulis ML, Stevenson K, Blonquist TM, Apsel Winger B, Cooper TM, Pauly M, Maloney KW, Burke MJ, Brown PA, Gossai N, McNeer JL, Shukla NN, Cole PD, Kahn JM, Chen J, Barth MJ, Magee JA, Gennarini L, Adhav AA, Clinton CM, Ocasio-Martinez N, Gotti G, Li Y, Lin S, Imamovic A, Tognon CE, Patel T, Faust HL, Contreras CF, Cremer A, Cortopassi WA, Garrido Ruiz D, Jacobson MP, Dharia NV, Su A, Robichaud AL, Saur Conway A, Tarlock K, Stieglitz E, Place AE, Puissant A, Hunger SP, Kim AS, Lindeman NI, Gore L, Janeway KA, Silverman LB, Tyner JW, Harris MH, Loh ML, Stegmaier K.
PMID: 33563661
Cancer Discov. 2021 Jun;11(6):1424-1439. doi: 10.1158/2159-8290.CD-20-0564. Epub 2021 Feb 09.

Despite a remarkable increase in the genomic profiling of cancer, integration of genomic discoveries into clinical care has lagged behind. We report the feasibility of rapid identification of targetable mutations in 153 pediatric patients with relapsed/refractory or high-risk leukemias...

Cite
Pikman Y, Tasian SK, Sulis ML, et al. Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium. Cancer Discov. 2021;11(6):1424-1439doi: 10.1158/2159-8290.CD-20-0564.
Pikman, Y., Tasian, S. K., Sulis, M. L., Stevenson, K., Blonquist, T. M., Apsel Winger, B., Cooper, T. M., Pauly, M., Maloney, K. W., Burke, M. J., Brown, P. A., Gossai, N., McNeer, J. L., Shukla, N. N., Cole, P. D., Kahn, J. M., Chen, J., Barth, M. J., Magee, J. A., Gennarini, L., Adhav, A. A., Clinton, C. M., Ocasio-Martinez, N., Gotti, G., Li, Y., Lin, S., Imamovic, A., Tognon, C. E., Patel, T., Faust, H. L., Contreras, C. F., Cremer, A., Cortopassi, W. A., Garrido Ruiz, D., Jacobson, M. P., Dharia, N. V., Su, A., Robichaud, A. L., Saur Conway, A., Tarlock, K., Stieglitz, E., Place, A. E., Puissant, A., Hunger, S. P., Kim, A. S., Lindeman, N. I., Gore, L., Janeway, K. A., Silverman, L. B., Tyner, J. W., Harris, M. H., Loh, M. L., & Stegmaier, K. (2021). Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium. Cancer discovery, 11(6), 1424-1439. https://doi.org/10.1158/2159-8290.CD-20-0564
Pikman, Yana, et al. "Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium." Cancer discovery vol. 11,6 (2021): 1424-1439. doi: https://doi.org/10.1158/2159-8290.CD-20-0564
Pikman Y, Tasian SK, Sulis ML, Stevenson K, Blonquist TM, Apsel Winger B, Cooper TM, Pauly M, Maloney KW, Burke MJ, Brown PA, Gossai N, McNeer JL, Shukla NN, Cole PD, Kahn JM, Chen J, Barth MJ, Magee JA, Gennarini L, Adhav AA, Clinton CM, Ocasio-Martinez N, Gotti G, Li Y, Lin S, Imamovic A, Tognon CE, Patel T, Faust HL, Contreras CF, Cremer A, Cortopassi WA, Garrido Ruiz D, Jacobson MP, Dharia NV, Su A, Robichaud AL, Saur Conway A, Tarlock K, Stieglitz E, Place AE, Puissant A, Hunger SP, Kim AS, Lindeman NI, Gore L, Janeway KA, Silverman LB, Tyner JW, Harris MH, Loh ML, Stegmaier K. Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium. Cancer Discov. 2021 Jun;11(6):1424-1439. doi: 10.1158/2159-8290.CD-20-0564. Epub 2021 Feb 09. PMID: 33563661; PMCID: PMC8178162.
Copy Download .nbib Format: NLM
Imaging Features of Hepatic Small Vessel Neoplasm: Case Series.

Hepatology (Baltimore, Md.)

Paisant A, Bellal S, Lebigot J, Canivet CM, Michalak S, Aubé C.
PMID: 34131938
Hepatology. 2021 Nov;74(5):2894-2896. doi: 10.1002/hep.31779. Epub 2021 Aug 30.

No abstract available.

Cite
Paisant A, Bellal S, Lebigot J, et al. Imaging Features of Hepatic Small Vessel Neoplasm: Case Series. Hepatology. 2021;74(5):2894-2896doi: 10.1002/hep.31779.
Paisant, A., Bellal, S., Lebigot, J., Canivet, C. M., Michalak, S., & Aubé, C. (2021). Imaging Features of Hepatic Small Vessel Neoplasm: Case Series. Hepatology (Baltimore, Md.), 74(5), 2894-2896. https://doi.org/10.1002/hep.31779
Paisant, Anita, et al. "Imaging Features of Hepatic Small Vessel Neoplasm: Case Series." Hepatology (Baltimore, Md.) vol. 74,5 (2021): 2894-2896. doi: https://doi.org/10.1002/hep.31779
Paisant A, Bellal S, Lebigot J, Canivet CM, Michalak S, Aubé C. Imaging Features of Hepatic Small Vessel Neoplasm: Case Series. Hepatology. 2021 Nov;74(5):2894-2896. doi: 10.1002/hep.31779. Epub 2021 Aug 30. PMID: 34131938.
Copy Download .nbib Format: NLM
Reliability Criteria of Two-Dimensional Shear Wave Elastography: Analysis of 4277 Measurements in 788 Patients.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Paisant A, Lemoine S, Cassinotto C, de Lédinghen V, Ronot M, Irlès-Depé M, Vilgrain V, Le Bail B, Paradis V, Canivet CM, Michalak S, Rousselet MC, Rautou PE, Lebigot J, Hunault G, Crouan A, Aubé C, Boursier J.
PMID: 33340779
Clin Gastroenterol Hepatol. 2020 Dec 16; doi: 10.1016/j.cgh.2020.12.013. Epub 2020 Dec 16.

BACKGROUND & AIMS: Two-dimensional shear wave elastography (2D-SWE) is an accurate method for the non-invasive evaluation of liver fibrosis. We aimed to determine the reliability criteria and the number of necessary reliable measurements for 2D-SWE.METHODS: 788 patients with chronic...

Cite
Paisant A, Lemoine S, Cassinotto C, et al. Reliability Criteria of Two-Dimensional Shear Wave Elastography: Analysis of 4277 Measurements in 788 Patients. Clin Gastroenterol Hepatol. 2020;doi: 10.1016/j.cgh.2020.12.013.
Paisant, A., Lemoine, S., Cassinotto, C., de Lédinghen, V., Ronot, M., Irlès-Depé, M., Vilgrain, V., Le Bail, B., Paradis, V., Canivet, C. M., Michalak, S., Rousselet, M. C., Rautou, P. E., Lebigot, J., Hunault, G., Crouan, A., Aubé, C., & Boursier, J. (2020). Reliability Criteria of Two-Dimensional Shear Wave Elastography: Analysis of 4277 Measurements in 788 Patients. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, . https://doi.org/10.1016/j.cgh.2020.12.013
Paisant, Anita, et al. "Reliability Criteria of Two-Dimensional Shear Wave Elastography: Analysis of 4277 Measurements in 788 Patients." Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association vol. (2020). doi: https://doi.org/10.1016/j.cgh.2020.12.013
Paisant A, Lemoine S, Cassinotto C, de Lédinghen V, Ronot M, Irlès-Depé M, Vilgrain V, Le Bail B, Paradis V, Canivet CM, Michalak S, Rousselet MC, Rautou PE, Lebigot J, Hunault G, Crouan A, Aubé C, Boursier J. Reliability Criteria of Two-Dimensional Shear Wave Elastography: Analysis of 4277 Measurements in 788 Patients. Clin Gastroenterol Hepatol. 2020 Dec 16; doi: 10.1016/j.cgh.2020.12.013. Epub 2020 Dec 16. PMID: 33340779.
Copy Download .nbib Format: NLM
Soil Fungal:Bacterial Ratios Are Linked to Altered Carbon Cycling.

Frontiers in microbiology

Malik AA, Chowdhury S, Schlager V, Oliver A, Puissant J, Vazquez PG, Jehmlich N, von Bergen M, Griffiths RI, Gleixner G.
PMID: 27555839
Front Microbiol. 2016 Aug 09;7:1247. doi: 10.3389/fmicb.2016.01247. eCollection 2016.

Despite several lines of observational evidence, there is a lack of consensus on whether higher fungal:bacterial (F:B) ratios directly cause higher soil carbon (C) storage. We employed RNA sequencing, protein profiling and isotope tracer techniques to evaluate whether differing...

Cite
Malik AA, Chowdhury S, Schlager V, et al. Soil Fungal:Bacterial Ratios Are Linked to Altered Carbon Cycling. Front Microbiol. 2016;7:1247doi: 10.3389/fmicb.2016.01247.
Malik, A. A., Chowdhury, S., Schlager, V., Oliver, A., Puissant, J., Vazquez, P. G., Jehmlich, N., von Bergen, M., Griffiths, R. I., & Gleixner, G. (2016). Soil Fungal:Bacterial Ratios Are Linked to Altered Carbon Cycling. Frontiers in microbiology, 71247. https://doi.org/10.3389/fmicb.2016.01247
Malik, Ashish A, et al. "Soil Fungal:Bacterial Ratios Are Linked to Altered Carbon Cycling." Frontiers in microbiology vol. 7 (2016): 1247. doi: https://doi.org/10.3389/fmicb.2016.01247
Malik AA, Chowdhury S, Schlager V, Oliver A, Puissant J, Vazquez PG, Jehmlich N, von Bergen M, Griffiths RI, Gleixner G. Soil Fungal:Bacterial Ratios Are Linked to Altered Carbon Cycling. Front Microbiol. 2016 Aug 09;7:1247. doi: 10.3389/fmicb.2016.01247. eCollection 2016. PMID: 27555839; PMCID: PMC4977315.
Copy Download .nbib Format: NLM
Quantitative genetics of gastrointestinal strongyle burden and associated body condition in feral horses.

International journal for parasitology. Parasites and wildlife

Gold S, Regan CE, McLoughlin PD, Gilleard JS, Wilson AJ, Poissant J.
PMID: 31011533
Int J Parasitol Parasites Wildl. 2019 Apr 06;9:104-111. doi: 10.1016/j.ijppaw.2019.03.010. eCollection 2019 Aug.

Variability in host resistance or tolerance to parasites is nearly ubiquitous, and is of key significance in understanding the evolutionary processes shaping host-parasite interactions. While ample research has been conducted on the genetics of parasite burden in livestock, relatively...

Cite
Gold S, Regan CE, McLoughlin PD, et al. Quantitative genetics of gastrointestinal strongyle burden and associated body condition in feral horses. Int J Parasitol Parasites Wildl. 2019;9:104-111doi: 10.1016/j.ijppaw.2019.03.010.
Gold, S., Regan, C. E., McLoughlin, P. D., Gilleard, J. S., Wilson, A. J., & Poissant, J. (2019). Quantitative genetics of gastrointestinal strongyle burden and associated body condition in feral horses. International journal for parasitology. Parasites and wildlife, 9104-111. https://doi.org/10.1016/j.ijppaw.2019.03.010
Gold, Susannah, et al. "Quantitative genetics of gastrointestinal strongyle burden and associated body condition in feral horses." International journal for parasitology. Parasites and wildlife vol. 9 (2019): 104-111. doi: https://doi.org/10.1016/j.ijppaw.2019.03.010
Gold S, Regan CE, McLoughlin PD, Gilleard JS, Wilson AJ, Poissant J. Quantitative genetics of gastrointestinal strongyle burden and associated body condition in feral horses. Int J Parasitol Parasites Wildl. 2019 Apr 06;9:104-111. doi: 10.1016/j.ijppaw.2019.03.010. eCollection 2019 Aug. PMID: 31011533; PMCID: PMC6462499.
Copy Download .nbib Format: NLM
Clinical Characteristics and Adverse Clinical Outcomes of Invasive Haemophilus influenzae Serotype a Cases-United States, 2011-2015.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Bozio CH, Blain A, Edge K, Farley MM, Harrison LH, Poissant T, Schaffner W, Scheuer T, Torres S, Triden L, Briere E, Oliver SE.
PMID: 32668450
Clin Infect Dis. 2021 Dec 06;73(11):e3670-e3676. doi: 10.1093/cid/ciaa990.

BACKGROUND: Incidence of invasive disease due to Haemophilus influenzae serotype a (Hia) increased an average of 13% annually from 2002 through 2015. We describe clinical characteristics and adverse clinical outcomes of US invasive Hia cases detected through multistate surveillance...

Cite
Bozio CH, Blain A, Edge K, et al. Clinical Characteristics and Adverse Clinical Outcomes of Invasive Haemophilus influenzae Serotype a Cases-United States, 2011-2015. Clin Infect Dis. 2021;73(11):e3670-e3676doi: 10.1093/cid/ciaa990.
Bozio, C. H., Blain, A., Edge, K., Farley, M. M., Harrison, L. H., Poissant, T., Schaffner, W., Scheuer, T., Torres, S., Triden, L., Briere, E., & Oliver, S. E. (2021). Clinical Characteristics and Adverse Clinical Outcomes of Invasive Haemophilus influenzae Serotype a Cases-United States, 2011-2015. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(11), e3670-e3676. https://doi.org/10.1093/cid/ciaa990
Bozio, Catherine H, et al. "Clinical Characteristics and Adverse Clinical Outcomes of Invasive Haemophilus influenzae Serotype a Cases-United States, 2011-2015." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 73,11 (2021): e3670-e3676. doi: https://doi.org/10.1093/cid/ciaa990
Bozio CH, Blain A, Edge K, Farley MM, Harrison LH, Poissant T, Schaffner W, Scheuer T, Torres S, Triden L, Briere E, Oliver SE. Clinical Characteristics and Adverse Clinical Outcomes of Invasive Haemophilus influenzae Serotype a Cases-United States, 2011-2015. Clin Infect Dis. 2021 Dec 06;73(11):e3670-e3676. doi: 10.1093/cid/ciaa990. PMID: 32668450.
Copy Download .nbib Format: NLM
Retraction Note: LAMP2 expression dictates azacytidine response and prognosis in MDS/AML.

Leukemia

Dubois A, Furstoss N, Calleja A, Zerhouni M, Cluzeau T, Savy C, Marchetti S, Hamouda MA, Boulakirba S, Orange F, Lacas-Gervais S, Karsenti JM, Mounier N, Tamburini J, Puissant A, Luciano F, Jacquel A, Auberger P, Robert G.
PMID: 32665699
Leukemia. 2020 Sep;34(9):2544. doi: 10.1038/s41375-020-0969-8.

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Cite
Dubois A, Furstoss N, Calleja A, et al. Retraction Note: LAMP2 expression dictates azacytidine response and prognosis in MDS/AML. Leukemia. 2020;34(9):2544doi: 10.1038/s41375-020-0969-8.
Dubois, A., Furstoss, N., Calleja, A., Zerhouni, M., Cluzeau, T., Savy, C., Marchetti, S., Hamouda, M. A., Boulakirba, S., Orange, F., Lacas-Gervais, S., Karsenti, J. M., Mounier, N., Tamburini, J., Puissant, A., Luciano, F., Jacquel, A., Auberger, P., & Robert, G. (2020). Retraction Note: LAMP2 expression dictates azacytidine response and prognosis in MDS/AML. Leukemia, 34(9), 2544. https://doi.org/10.1038/s41375-020-0969-8
Dubois, Alix, et al. "Retraction Note: LAMP2 expression dictates azacytidine response and prognosis in MDS/AML." Leukemia vol. 34,9 (2020): 2544. doi: https://doi.org/10.1038/s41375-020-0969-8
Dubois A, Furstoss N, Calleja A, Zerhouni M, Cluzeau T, Savy C, Marchetti S, Hamouda MA, Boulakirba S, Orange F, Lacas-Gervais S, Karsenti JM, Mounier N, Tamburini J, Puissant A, Luciano F, Jacquel A, Auberger P, Robert G. Retraction Note: LAMP2 expression dictates azacytidine response and prognosis in MDS/AML. Leukemia. 2020 Sep;34(9):2544. doi: 10.1038/s41375-020-0969-8. PMID: 32665699; PMCID: PMC7449876.
Copy Download .nbib Format: NLM
Atmospheric particle evolution during a nighttime atmospheric mercury depletion event in sub-Arctic at Kuujjuarapik/Whapmagoostui, Québec, Canada.

The Science of the total environment

Gauchard PA, Ferrari CP, Dommergue A, Poissant L, Pilote M, Guehenneux G, Boutron CF, Baussand P.
PMID: 15589260
Sci Total Environ. 2005 Jan 05;336(1):215-24. doi: 10.1016/j.scitotenv.2004.05.022.

During a field experiment at Kuujjuarapik/Whapmagoostui (55.31 degrees N, 77.75 degrees W), Quebec, we observed increases of concentrations of particles with diameters larger than 0.3 microm in the ambient air during a nighttime atmospheric mercury depletion event (AMDE). These...

Cite
Gauchard PA, Ferrari CP, Dommergue A, et al. Atmospheric particle evolution during a nighttime atmospheric mercury depletion event in sub-Arctic at Kuujjuarapik/Whapmagoostui, Québec, Canada. Sci Total Environ. 2005;336(1):215-24doi: 10.1016/j.scitotenv.2004.05.022.
Gauchard, P. A., Ferrari, C. P., Dommergue, A., Poissant, L., Pilote, M., Guehenneux, G., Boutron, C. F., & Baussand, P. (2005). Atmospheric particle evolution during a nighttime atmospheric mercury depletion event in sub-Arctic at Kuujjuarapik/Whapmagoostui, Québec, Canada. The Science of the total environment, 336(1), 215-24. https://doi.org/10.1016/j.scitotenv.2004.05.022
Gauchard, Pierre-Alexis, et al. "Atmospheric particle evolution during a nighttime atmospheric mercury depletion event in sub-Arctic at Kuujjuarapik/Whapmagoostui, Québec, Canada." The Science of the total environment vol. 336,1 (2005): 215-24. doi: https://doi.org/10.1016/j.scitotenv.2004.05.022
Gauchard PA, Ferrari CP, Dommergue A, Poissant L, Pilote M, Guehenneux G, Boutron CF, Baussand P. Atmospheric particle evolution during a nighttime atmospheric mercury depletion event in sub-Arctic at Kuujjuarapik/Whapmagoostui, Québec, Canada. Sci Total Environ. 2005 Jan 05;336(1):215-24. doi: 10.1016/j.scitotenv.2004.05.022. PMID: 15589260.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 50 entries